In CRC, TSC1 frequently exhibits genomic loss or transcriptional downregulation, correlating with advanced disease, poor prognosis, and reduced CD8+ T-cell infiltration (24, 25). The gene discussed is TSC1; the disease is colorectal carcinoma.